Table 2.
Nucleus | 8 weeks |
12 weeks |
16 weeks |
|||
---|---|---|---|---|---|---|
WT | SOD | WT | SOD | WT | SOD | |
ABD | 32.85 ± 4.26 | 23.44 ± 0.93 | 22.25 ± 3.36 | 11.22 ± 1.60 | 17.53 ± 2.89 | 15.18 ± 2.43 |
TROC | 32.83 ± 2.83 | 23.71 ± 1.29 | 24.77 ± 2.67 | 12.46 ± 3.20 | 16.86 ± 3.14 | 15.93 ± 2.43 |
OCM | 27.17 ± 3.31 | 22.87 ± 1.55 | 21.54 ± 3.17 | 13.10 ± 1.86 | 18.63 ± 1.57 | 14.15 ± 0.84 |
FACIAL | 13.41 ± 3.50 | 14.20 ± 0.80 | 10.04 ± 0.58 | 3.30 ± 0.16 | 7.72 ± 0.68 | 5.65 ± 0.78 |
HYPO | 12.15 ± 1.82 | 14.08 ± 0.55 | 8.40 ± 0.41 | 3.88 ± 0.37 | 7.53 ± 0.66 | 5.83 ± 0.65 |
Optical density of VEGF immunohistochemistry in brainstem nuclei of WT and SOD mice at the different stages of survival. Data are expressed as mean ± standard error of the mean.